PubRank

Daniela M Ferreira

Author PubWeight™ 13.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology 2009 1.37
2 Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog 2012 1.18
3 Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J Med Microbiol 2008 1.14
4 Experimental human pneumococcal carriage. J Vis Exp 2013 1.09
5 Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection. Clin Vaccine Immunol 2010 1.06
6 T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog 2012 1.01
7 Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog 2013 1.01
8 Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice. PLoS One 2010 0.98
9 Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect 2008 0.94
10 Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infect Immun 2002 0.94
11 Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice. Clin Vaccine Immunol 2012 0.81
12 Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae. Microb Pathog 2012 0.81
13 Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clin Vaccine Immunol 2012 0.78
14 Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis. Shock 2016 0.78
15 Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults. Vaccine 2013 0.76
16 Elicitation of mucosal immunity by proteins of Streptococcus pneumoniae. Adv Otorhinolaryngol 2011 0.75